Name
AMR Apteegid OÜ
Registry code
14903527
VAT number
EE102241796
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
03.02.2020 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
11 492 209 €
-192 429 €
-2%
-
-345 320 €
49
Submitted
No tax arrears
56%
-10%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Anne-Mai Rogenbaum 28.05.1982 (42) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
2020 07.07.2021 | 2021 01.07.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
---|---|---|---|---|
Total Revenue | 5 870 857 € | 8 330 257 € | 10 939 253 € | 11 492 209 € |
Net profit (loss) for the period | -215 515 € | -84 227 € | 144 352 € | -192 429 € |
Profit Margin | -4% | -1% | 1% | -2% |
Current Assets | 1 273 654 € | 1 257 183 € | 1 734 608 € | 1 848 651 € |
Fixed Assets | - | - | 11 364 € | 8 630 € |
Total Assets | 1 273 654 € | 1 257 183 € | 1 745 972 € | 1 857 281 € |
Current Liabilities | 1 486 669 € | 1 554 425 € | 1 898 862 € | 2 202 601 € |
Non Current Liabilities | - | - | - | - |
Total Liabilities | - | - | - | - |
Share Capital | - | - | - | - |
Equity | -213 015 € | -297 242 € | -152 890 € | -345 320 € |
Employees | 34 | 44 | 47 | 49 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 3 233 191.12 € | 208 777.93 € | 178 231.9 € | 63 |
2023 Q4 | 3 048 741.69 € | 191 470.57 € | 175 246.89 € | 65 |
2023 Q3 | 3 004 255.24 € | 200 499.26 € | 179 543.67 € | 65 |
2023 Q2 | 3 141 946.65 € | 195 496.9 € | 172 096.58 € | 67 |
2023 Q1 | 3 202 128.55 € | 206 204.54 € | 179 477.55 € | 68 |
2022 Q4 | 3 083 454.69 € | 159 368.49 € | 151 496.52 € | 70 |
2022 Q3 | 2 887 919.15 € | 180 935.31 € | 146 129.77 € | 65 |
2022 Q2 | 2 844 313.75 € | 159 093.23 € | 131 533.86 € | 65 |
2022 Q1 | 2 728 730.49 € | 168 799.13 € | 126 802.51 € | 66 |
2021 Q4 | 2 666 253.69 € | 147 922.64 € | 121 183.66 € | 65 |
2021 Q3 | 1 981 391.35 € | 143 595.55 € | 115 253.07 € | 62 |
2021 Q2 | 2 097 764.13 € | 129 661 € | 113 036.13 € | 56 |
2021 Q1 | 2 029 107.71 € | 141 045.41 € | 118 750.05 € | 59 |
2020 Q4 | 2 275 340.97 € | 145 750.52 € | 125 434.52 € | 57 |
2020 Q3 | 2 184 911.55 € | 137 910.06 € | 111 955.99 € | 54 |
2020 Q2 | 1 100 126.21 € | 55 000.61 € | 50 672.52 € | 55 |
2020 Q1 | - | - | - | 59 |